HESTERBIOBSEHester Biosciences LtdMinimalNeutral
Announced Mon, 18 May · 09:58 IST

Annual Secretarial Compliance Report for the year ended 31 March 2026

HESTERBIO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.5%1-day move
₹1824.00
prior close
₹1810.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1-0.5-1.0-1.0-0.5+0.9+3.3+3.8+4.4+8.6+5.3+14.6+36.6
Up moveDown movePending
AI summary

Hester Biosciences Ltd has submitted its Annual Secretarial Compliance Report for FY 2025-26, verified by Practicing Company Secretary Tapan Shah. The report confirms the company has generally complied with all material provisions of applicable SEBI Regulations including LODR 2015, Insider Trading Regulations, and Depositories Regulations. All 13 compliance checkpoints including secretarial standards, website disclosures, director disqualification checks, related party transactions, and preservation of documents show 'Yes' or 'NA' status. No actions have been taken against the company, its promoters, or directors by SEBI or stock exchanges. A minor procedural note indicates the CFO appointment was initially done via circular resolution but was subsequently ratified in a Board meeting.

Likely market impact

This is a positive regulatory filing indicating clean compliance with SEBI requirements. No shareholder action is required as no non-compliances, penalties, or material observations were reported for the period.